Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 known ✓ | P21453 | 2/20 | 0.36 |
| ▸ | S1PR4 known ✓ | O95977 | 1/20 | 0.34 |
| ▸ | S1PR3 known ✓ | Q99500 | 1/20 | 0.34 |
| ▸ | S1PR5 known ✓ | Q9H228 | 1/20 | 0.34 |
| ▸ | HDAC1 known ✓ | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC11 known ✓ | Q96DB2 | 1/20 | 0.33 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 known ✓ | Q9UBN7 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 9/20 | 0.43 |
| ▸ | CNR1 | P21554 | 7/20 | 0.43 |
| ▸ | TNNC1 | P63316 | 5/20 | 0.34 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.34 |
| ▸ | GPR183 | P32249 | 1/20 | 0.34 |
| ▸ | CERS2 | Q96G23 | 1/20 | 0.34 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.34 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1485770 | 1.00 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| Hydrochloric Acid SCHEMBL9346395 | 1.00 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| Hydrochloric Acid SCHEMBL8172128 | 1.00 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| Hydrochloric Acid SCHEMBL11053875 | 1.00 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| SCHEMBL3815476 | 0.98 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| SCHEMBL17800826 | 0.98 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| SCHEMBL372803 | 0.98 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| SCHEMBL6900997 | 0.98 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| SCHEMBL17800818 | 0.98 | CNR2 (0.43) | CNR2CNR1S1PR1TNNC1SGPL1 | |
| Hydrochloric Acid SCHEMBL10760883 | 0.98 | CNR2 (0.40) | CNR2CNR1S1PR1TNNC1SGPL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114342931-A | Improved method of solid chlorine preparation with fragrance | 李文昌 | 2022-04-15 | — | — | CN | claimed |
| EP-1885326-A2 | REGULATION OF MAMMALIAN KERATINOUS TISSUE USING PERSONAL CARE COMPOSITIONS COMPRISING CETYL PYRIDINIUM CHLORIDE | The Procter and Gamble Company (US) | 2008-02-13 | — | — | EP | claimed |
| US-20070020221-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride | PROCTER & GAMBLE COMPANY, THE | 2007-01-25 | — | — | US | claimed |
| EP-1556473-A4 | A MULTI COMPONENT CONTROLLED DELIVERY SYSTEM FOR SOAP BARS | SALVONA LLC (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2006124990-A2 | REGULATION OF MAMMALIAN KERATINOUS TISSUE USING PERSONAL CARE COMPOSITIONS COMPRISING CETYL PYRIDINIUM CHLORIDE | THE PROCTER & GAMBLE COMPANY (US) | 2006-11-23 | — | — | WO | claimed |
| WO-2006036617-A1 | A MULTI-COMPONENT CONTROLLED DELIVERY SYSTEM FOR SOAP BARS | SALVONA LLC (US) | 2006-04-06 | — | — | WO | claimed |
| EP-1556473-A1 | A MULTI COMPONENT CONTROLLED DELIVERY SYSTEM FOR SOAP BARS | Salvona L.L.C. (US) | 2005-07-27 | — | — | EP | claimed |
| US-6825161-B2 | IMPROVED CONTROLLED DELIVERY SYSTEM THAT CAN BE INCORPORATED IN SOAP BARS TO ENHANCE DEPOSITION OF ACTIVE INGREDIENTS AND SENSORY MARKERS ONTO SKIN. THE CARRIER SYSTEM ALSO PROVIDES CONTROLLED RELEASE OR PROLONGED RELEASE OF THESE ACTIVES FROM | SALVONA LLC | 2004-11-30 | — | — | US | claimed |
| WO-2004041991-A1 | A MULTI COMPONENT CONTROLLED DELIVERY SYSTEM FOR SOAP BARS | SALVONA LLC (US) | 2004-05-21 | — | — | WO | claimed |
| US-20030207776-A1 | Multi component controlled delivery system for soap bars | SHEFER ADI (US) | 2003-11-06 | — | — | US | claimed |
| US-5143518-A | Fatty Acid Soap, Silicone, Cationic Surfactant, Base, Cationic Polymer | L'OREAL (FR) | 1992-09-01 | — | — | US | claimed |
| US-5134210-A | Acrylic resin composition | QUEST TECHNOLOGIES, INC. | 1992-07-28 | — | — | US | claimed |
| US-5073587-A | Polymeric composition and method of producing same | QUEST TECHNOLOGIES, INC. | 1991-12-17 | — | — | US | claimed |
| US-5008345-A | Two-Part Curing System Containing A Metallic Acid Salt And An Ammonium Or Phosphonium Quaternary Salt | ZEON CHEMICAL USA, INC. (US) | 1991-04-16 | — | — | US | claimed |
| WO-1991002022-A1 | ACRYLIC RESIN COMPOSITION | EDWARDS BILL R (US) | 1991-02-21 | — | — | WO | claimed |
| US-4945122-A | Acrylic resin composition | QUEST TECHNOLOGIES, INC. | 1990-07-31 | — | — | US | claimed |
| US-4841016-A | Polyester resin compositions | QUEST TECHNOLOGIES, INC. | 1989-06-20 | — | — | US | claimed |
| US-4820308-A | AMINE-SUBSTITUTED POLYSILOXANES, QUATERNIZED CELLULOSE ETHERS, CYCLOPOLYMERS | L'OREAL (FR) | 1989-04-11 | — | — | US | claimed |
| EP-0309794-A2 | No-post-cure method of curing polyacrylate polymers | Zeon Chemicals USA, Inc. (US) | 1989-04-05 | — | — | EP | claimed |
| US-4710314-A | BLEND OF SOAP, CATION OLYMERS AND SURFACTANTS | L'OREAL (FR) | 1987-12-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070020221-A1 | Regulation of mammalian keratinous tissue using personal care compositions comprising cetyl pyridinium chloride | RBP1, PROC, RBP4 | S1PR1 1641/4885S1PR4 2419/4885S1PR3 1307/4885 |
| US-20030207776-A1 | Multi component controlled delivery system for soap bars | CHMP4B, S100P, CUTA | S1PR1 2746/4885S1PR4 2495/4885S1PR3 2713/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.